Safety Sciences Research, Pfizer Inc, New York, NY, USA; Department of Medicine, NYU Langone Health, New York, NY, USA.
Pharmaceutical Physician, Kent, United Kingdom.
Clin Ther. 2021 Feb;43(2):372-379. doi: 10.1016/j.clinthera.2020.12.014. Epub 2021 Jan 18.
Artificial intelligence (AI), a highly interdisciplinary science, is an increasing presence in pharmacovigilance (PV). A better understanding of the scope of artificial intelligence in pharmacovigilance (AIPV) may be advantageous to more sharply defining, for example, which terms, methods, tasks, and data sets are suitably subsumed under the application of AIPV. Accordingly, this article explores relevant points to consider regarding defining the scope of AIPV and offers a potential working definition of the scope of AIPV.
人工智能(AI)是一门高度交叉的科学,在药物警戒(PV)中越来越常见。更好地了解人工智能在药物警戒中的应用(AIPV)的范围,可能有助于更准确地定义,例如,哪些术语、方法、任务和数据集适合归入 AIPV 的应用范围。因此,本文探讨了定义 AIPV 范围时需要考虑的相关要点,并提出了 AIPV 范围的潜在工作定义。